Volume 43, Issue 3 pp. 805-815
ORIGINAL ARTICLE

Analysis of palliative care treatment among head and neck patients with cancer: National perspective

Christopher Blake Sullivan MD

Christopher Blake Sullivan MD

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Search for more papers by this author
Zaid Al-Qurayshi MD, MPH

Zaid Al-Qurayshi MD, MPH

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Search for more papers by this author
Kristi Chang MD

Kristi Chang MD

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Search for more papers by this author
Nitin A. Pagedar MD, MPH

Corresponding Author

Nitin A. Pagedar MD, MPH

Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Correspondence

Nitin A. Pagedar, MD, MPH, Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, 200 Hawkins Drive, Iowa City, IA 52242.

Email: [email protected]

Search for more papers by this author
First published: 05 November 2020
Citations: 6

Abstract

Background

To analyze the characteristics and survival patterns of patients with head and neck squamous cell carcinoma (SCC) who received palliative treatment during their first course of treatment.

Methods

Cohort analysis utilizing the National Cancer Data Base (NCDB) of patients with a diagnosis of oral cavity/oropharyngeal, hypopharyngeal, and laryngeal SCC. Statistical analysis included multivariate logistic regression and Cox Hazard ratio modeling, and Kaplan-Meier survival analysis.

Results

165 081 patients were included, of which 2747 patients received palliative treatment. Patients who received palliative treatment tended to be ≥65 years old, black, Charlson/Deyo score ≥3, hypopharyngeal cancer, stage (III-IV), with Medicaid insurance (P < .05). Patients were more likely to be treated with palliative intent if they underwent chemotherapy/radiotherapy and declined surgery (P < .001) compared to patients who underwent surgery and declined chemotherapy/radiotherapy (P = .006).

Conclusions

Palliative care use in head and neck oncology is associated with older patients, non-whites, Medicaid patients, and nonsurgically treated patients.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support this article is available through the National Cancer Database program. Access must be granted by the institution.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.